Pharmaceuticals This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 15.

PhRMA attacks Obama's proposals to cut Medicare payments
Plans by US President Barack Obama to cut medicare payments have been met with a backlash from the country's pharmaceutical industry.
Source: Pharmaceutical Technology - February 13, 2013 Category: Pharmaceuticals Source Type: news

Peregrine reports top-line results from Phase II pancreatic cancer study
Peregrine Pharmaceuticals has reported top-line results from a Phase II study evaluating bavituximab in combination with gemcitabine in stage IV pancreatic cancer patients.
Source: Drug Development Technology - February 13, 2013 Category: Pharmaceuticals Source Type: news

OncoGenex announces commencement of OGX-427 Phase II genitourinary cancer study
OncoGenex Pharmaceuticals has announced the commencement of a fourth Phase II genitourinary (GU) cancer study, as part of its OGX-427 Overcoming Resistance in Cancer (ORCA) programme.
Source: Drug Development Technology - February 13, 2013 Category: Pharmaceuticals Source Type: news

Multisorb Boosts Global Presence With Appointment Of Business Manager For Healthcare Packaging Group In India
Multisorb Technologies announces the appointment of Mr. Laxmikant Khaitan to the position of Business Manager – Healthcare Packaging India as part of its latest step in global expansion.
Source: Pharmaceutical Online News - February 13, 2013 Category: Pharmaceuticals Source Type: news

Ross Offers New PowerMix Planetary Disperser For No-Charge Testing
Ross Technical Director Ken Langhorn announces the addition of a new 10-gallon PowerMix Planetary Disperser to the Ross Test & Development Center.
Source: Pharmaceutical Online News - February 13, 2013 Category: Pharmaceuticals Source Type: news

Teva Faces Possible Damages From Selling Generic Protonix
Teva Pharmaceutical Industries may be on the hook for up to $2.1 billion in damages because it sold generic copies of Pfizer's heartburn reliever Protonix before the drug's U.S. patent exclusivity expired in 2011.
Source: WSJ.com: Health - February 13, 2013 Category: Pharmaceuticals Tags: PAID Source Type: news

Hard And Fast Or Slow And Steady? Choice Of Exercise Matters To Health, Study Says
The shameful amount of time we spend sitting every day, which seems somehow to be growing, is a killer – literally. There’s been a lot of debate in recent years about which kinds of exercise are best for us in the long run, and which might foil the curse of the sedentary lifestyle. Some studies have shown that short bouts of intense activity may be best, while others have supported the benefits of less vigorous, more drawn-out activity. Even doing chores or puttering around the house can accumulate to benefit our health. But most every study agrees that sitting for extended periods of time will lead us down a road...
Source: Forbes.com Healthcare News - February 13, 2013 Category: Pharmaceuticals Authors: Alice G. Walton Source Type: news

Four Key Questions for Health-Care Law
Even by Washington standards, implementing "Obamacare" is extraordinarily complex. David Wessel takes a look at the "four major hanging chads."
Source: WSJ.com: Health - February 13, 2013 Category: Pharmaceuticals Tags: FREE Source Type: news

QIAGEN Enters Into Broad Collaboration Agreement With Lilly for the Development and Commercialization of Companion Diagnostics
GERMANTOWN, Maryland and HILDEN, Germany, February 13, 2013 /PRNewswire/ -- Arrangement to facilitate future collaborations in personalized medicine Provides framework to develop and commercialize QIAGEN companion diagnostics paired with Lilly...
Source: Drugs.com - Pharma News - February 13, 2013 Category: Pharmaceuticals Source Type: news

FDA Approves Second Generation MRI-Friendly Pacemaker System From Medtronic
Medtronic announced today that the FDA had approved its Advisa DR MRI SureScan, a next generation pacemaker system specifically designed and tested for use with MRI scanners. The system, which Medtronic said would be launched immediately, includes the Advisa MRI device and two CapSureFix MRI SureScan leads.
Source: Forbes.com Healthcare News - February 13, 2013 Category: Pharmaceuticals Authors: Larry Husten Source Type: news

FDA Safety Regs Faulted for Lax Oversight
The Office of the Inspector General (OIG)
Source: Forbes.com Healthcare News - February 13, 2013 Category: Pharmaceuticals Authors: Scott Gottlieb Source Type: news

Sanofi to Refocus Drug R&D on Disease Biology
Elias Zerhouni, Sanofi's head of R&D, is refocusing his efforts on boosting the number and quality of the French firm's drug discoveries, by developing a better understanding there of how diseases work and how to target them.
Source: WSJ.com: Health - February 13, 2013 Category: Pharmaceuticals Tags: PAID Source Type: news

The Triangle’s largest bio/pharma companies slideshow
News concerning biotechnology/pharmaceutical companies either based in the Triangle or with a significant presence here seems to surface almost every day. Whether it’s good news on a major multiple sclerosis drug at Biogen Idec, bioMerieux’s $48 milion expansion in Durham or a Pfizer spinoff with local ties debuting on the New York Stock Exchange, the Triangle plays a major role in the overall bio/pharma scene. The Triangle plays host to a number of critical operations for some major players…
Source: bizjournals.com Health Care:Hospitals headlines - February 13, 2013 Category: Hospital Management Authors: Cameron Snipes Source Type: research

3 ways big pharma uses big data
In the world of Big Pharma, big data is a looming giant that can be a tough beast to tackle, but it can be a rewarding one too. With a vast amount of data in myriad formats, the Ecuadorian arm of Pfizer knew that using Excel spreadsheets to record and analyze marketing, sales, and distribution data was a Stone Age solution for their Space Age needs. They turned to Noux, an Ecuador-based company that works with SAP to implement a more nimble data-driven system to help with their business intelligence. read more
Source: Healthcare IT News - February 13, 2013 Category: Information Technology Authors: Benjamin Harris Tags: Online Only Big Pharma Bolivia Bolivia Ecuador Burbano de Lara business intelligence Eduardo Saenz Noux Saenz Per Pfizer World Health Organization Data Warehousing Source Type: news

Merck Statement on Venezuelan Currency Devaluation
Merck Confirms 2013 Full-Year Guidance and Provides Guidance on First Quarter WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Feb 13, 2013 - Merck, known as MSD outside the United States and Canada, said today that it has completed a preliminary...
Source: Drugs.com - Pharma News - February 13, 2013 Category: Pharmaceuticals Source Type: news

Trial sans Error: How Pharma-Funded Research Cherry-Picks Positive Results [Excerpt]
Excerpt from Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients , by Ben Goldacre. Published by Faber and Faber, Inc. © 2013 Ben Goldacre. Excerpted with permission from the publisher. All Rights Reserved. [More]
Source: Scientific American - Official RSS Feed - February 13, 2013 Category: Science Tags: Health,Pharmaceuticals,Society & Policy,Ethics,Biology,Health Source Type: research

15 Top Foreign Retirement Havens
Living overseas is different from just visiting. Before you retire to a foreign country, consider not just the weather and cost of living, but also healthcare; safety; tax and visa requirements; and how friendly the country is to foreigners. Here are some possibilities.
Source: Forbes.com Healthcare News - February 13, 2013 Category: Pharmaceuticals Authors: Deborah L. Jacobs Source Type: news

Travel Insurance Aimed At Active Boomers
Go ahead: Explore Tibet, bike the Alps and run the rapids--just pack a little extra insurance.
Source: Forbes.com Healthcare News - February 13, 2013 Category: Pharmaceuticals Authors: Deborah L. Jacobs Source Type: news

Down The RICO Rabbit Hole: John Reynolds And The Hospital For Special Surgery
To state that the federal RICO statue has long since slipped the bounds of Congress’s original intent is hardly a novel observation. Although the U.S. Attorney’s Manual points out that “the purpose of the RICO statute is ‘the elimination of the infiltration of organized crime and racketeering into legitimate organizations,’” the very same paragraph of the Manual proclaims that “the statute is sufficiently broad to encompass illegal activities relating to any enterprise affecting interstate or foreign commerce.” The varied range of successful federal prosecutions premised on the RICO statute only...
Source: Forbes.com Healthcare News - February 13, 2013 Category: Pharmaceuticals Authors: Robert Radick Source Type: news

Prostate Cancer Patients Treated with Proton Therapy at Loma Linda University Medical Center Show Excellent Quality of Life
New Breakthrough Report Reaffirms Proton Therapy Efficacy; Post-Treatment Quality of Life on Par with Men Never Afflicted by Cancer LOMA LINDA, Calif.--(Healthcare Sales & Marketing Network)--A staggering 99 percent of prostate cancer patients treated w... Devices, OncologyLoma Linda University Medical Center, proton therapy, radiotherapy, proton beam
Source: HSMN NewsFeed - February 13, 2013 Category: Pharmaceuticals Source Type: news

A Biotech Perspective On Why We Shouldn't Cut The NIH
The United States' $845 billion budget deficit (that's a 2013 forecast) certainly poses real threats to business. But there are some cuts would be just unwise, and in his State of the Union speech last night Barack Obama argued that spending on scientific and technological research is one of them.
Source: Forbes.com Healthcare News - February 13, 2013 Category: Pharmaceuticals Authors: Matthew Herper Source Type: news

Report: Tracking System Needed to Fight Fake Drugs
From Associated Press (February 13, 2013) WASHINGTON -- Fighting the problem of fake drugs will require putting medications through a chain of custody like U.S. courts require for evidence in a trial, the Institute of Medicine...
Source: Drugs.com - Pharma News - February 13, 2013 Category: Pharmaceuticals Source Type: news

ER Doc's Letter To Surviving Spouse Goes Viral (2M+ hits) On Reddit
Last year I wrote a piece that referenced a study released by Xerox. The study itself highlighted what Xerox found was often a missing element in healthcare – the human element. This last December, an emergency room doc (thought to be female based on the handwriting) wrote a note to the widow of a patient she had treated in the Emergency Department of New York Presbyterian Hospital. Over the course of this last week, the note itself (names redacted) surfaced through one of the family members on Reddit – and went viral. At last count it had over 2 million hits. The compassionate letter it...
Source: Forbes.com Healthcare News - February 13, 2013 Category: Pharmaceuticals Authors: Dan Munro Source Type: news

Administrative Sanction Related to Voluntary Recall of Alinamin-F5 Injection in Japan
Osaka, Japan, February 13, 2013 --- Takeda Pharmaceutical Company Limited (“Takeda”) today received an Order for Corrective Action regarding the manufacturing and marketing of ALINAMIN®-F5 Injection from the Osaka Prefectural...
Source: Drugs.com - Pharma News - February 13, 2013 Category: Pharmaceuticals Source Type: news

Drugs.com Releases Q4 Sales for Top 100 U.S. Drugs
Abilify Overtakes Nexium as the Top Drug by Sales NEW YORK, Feb. 13, 2013 /PRNewswire/ -- Drugs.com, the leading online clinical drug resource, today released fourth quarter 2012 U.S. prescription sales data for the top 100 drugs. At the...
Source: Drugs.com - Pharma News - February 13, 2013 Category: Pharmaceuticals Source Type: news

Merck Statement on Venezuelan Currency Devaluation
Dateline City: WHITEHOUSE STATION, N.J. Merck Confirms 2013 Full-Year Guidance and Provides Guidance on First Quarter WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, said today that it has completed a preliminary assessment of the impact of the Venezuelan government’s intention to devalue its currency effective Feb. 13, 2013. Language: English Contact HTML: MerckMedia:Ron Rogers, 908-423-6449Steve...
Source: Merck.com - Corporate News - February 13, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Corporate News Financial News Source Type: news

Vanda Takes Bigger Loss on Sleep Drug Development
From Associated Press (February 12, 2013) WASHINGTON -- Vanda Pharmaceuticals Inc. said Tuesday that it took a wider fourth-quarter loss as it spent more money to develop an experimental sleep-disorder drug, and revenue from a schizophrenia drug...
Source: Drugs.com - Pharma News - February 13, 2013 Category: Pharmaceuticals Source Type: news

Japanese pharma cos keen on tie-ups with Indian companies
A delegation of pharmaceutical firms from Japan's Toyama prefecture today indicated that Japanese companies are keen to collaborate with Indian pharma companies.
Source: The Economic Times Healthcare and Biotech News - February 13, 2013 Category: Pharmaceuticals Source Type: news

Arthritis Pain Drug Should Be Pulled Due to Adverse Heart Effects: Study
From Canadian Press DataFile (February 12, 2013) By Sheryl Ubelacker TORONTO -- Researchers are calling for the removal of a widely used pain medication from worldwide markets due to a high risk of heart attack and other adverse cardiovascular...
Source: Drugs.com - Pharma News - February 13, 2013 Category: Pharmaceuticals Source Type: news

Maximize Containment With The Task-specific Workstation
Flow Sciences's Task-specific workstations can meet the challenges and end user can experience with other laboratory workstations.
Source: Pharmaceutical Online News - February 13, 2013 Category: Pharmaceuticals Source Type: news

Reckitt gets taste for Chinese remedy
The group behind Nurofen, Strepsils and Durex condoms buys Oriental Medicine Company to add more holistic treatments to its portfolio
Source: FT.com - Drugs and Healthcare - February 13, 2013 Category: Pharmaceuticals Source Type: news

Mallinckrodt will promote and distribute Rapiscan® in France, Italy, Belgium, and Spain
Rapidscan Pharma Solutions (RPS) EU Ltd has announced that they have come to agreement with Mallinckrodt Medical BV (Mallinckrodt) for the exclusive right to promote and distribute Rapiscan® (regadenoson) in France, Italy, Belgium and Spain.
Source: Pharmacy Europe - February 13, 2013 Category: Drugs & Pharmacology Source Type: news

Janssen Healthcare Innovation launches inaugural Innovation Challenge Prize for Dementia in collaboration with the NHS(Feb 13, 2013)
LONDON, 13 February 2013 – Today Janssen Healthcare Innovation, an entrepreneurial team within Janssen Research & Development, LLC (Janssen), in partnership with the National Health Service (NHS), announced the launch of the inaugural NHS Innovation Challenge Prize for Dementia.....
Source: Johnson and Johnson - February 13, 2013 Category: Pharmaceuticals Source Type: news

02.14.13 -- Dosing For Effect: Getting It Right The First Time
02/14/13 Pharmaceutical Online Newsletter
Source: Pharmaceutical Online News - February 13, 2013 Category: Pharmaceuticals Source Type: news

Institute of Medicine Seeks to Combat Conterfeit Drug Problem
Fighting the problem of fake drugs will require putting medications through a chain of custody like U.S. courts require for evidence in a trial, the Institute of Medicine reported Wednesday.The call for a national drug tracking system comes a week after the Food and Drug Administration warned doctors, for the third time in about a year, that it discovered a counterfeit batch of the cancer drug Avastin that lacked the real tumor-killing ingredient.
Source: PharmaManufacturing.com - February 13, 2013 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news

Tips for Using Online Pharmacies
Check out this video on "CBS This Morning" where Economist Roger Bate, the author of "Phake," spoke candidly about the counterfeit drug problem online and how to protect yourself.
Source: PharmaManufacturing.com - February 13, 2013 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news

Facing the Pharmaceutical Future
Emerging trends in pharmaceutical manufacturing processes will spur innovation, competitive vitality and safety
Source: PharmaManufacturing.com - February 13, 2013 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news

6 Tips for Mitigating Manufacturing Risk
Medical device manufacturers partner with contract manufacturers to identify potential risks and help produce safe, reliable, high-quality products
Source: PharmaManufacturing.com - February 13, 2013 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news

Colorado lawmakers' vote on 'biosimilar' drugs draws international attention
A bill requiring that a Colorado patient's doctor be notified if a pharmacist substitutes a biotech generic for a brand-name biotech drug cleared its first committee at the state Legislature Tuesday. The 10-1 vote by the House Health, Insurance & Environment committee wasn't a surprise. What was unusual was the representatives of big pharma, large medical trade groups and health care nonprofits coming from as far as Germany to testify in a crowded basement room at the Capitol in Denver at the first…
Source: bizjournals.com Health Care:Biotechnology headlines - February 13, 2013 Category: Biotechnology Authors: Greg Avery Source Type: research

Radium-223 Dichloride Granted Priority Review by U.S. FDA (for specialized target groups only)
Source: Bayer Company News - February 13, 2013 Category: Pharmaceuticals Source Type: news

'Mr. Speaker, The President of the United States...and Jack Andraka!'
By now, Jack Andraka is almost a household name. He's rubbed shoulders with leading scientists and physicians. And tonight he'll do the same with the President Obama at the State of the Union address at the Capital. His achievement in cancer research has catapulted this 15 year-old onto the global stage. His national acclaim began when he was awarded the first-place Gordon E. Moore Award for his new method to detect pancreatic cancer at the 2012 Intel International Science and Engineering Fair, a program of the Society for Science & the Public. The prize, named in honor of Intel's cofou...
Source: Forbes.com Healthcare News - February 13, 2013 Category: Pharmaceuticals Authors: John Nosta Source Type: news

PharmaSecure Approved To Begin Operations In Nigeria
On January 31st, Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) endorsed PharmaSecure to begin operations in Nigeria.
Source: Pharmaceutical Online News - February 13, 2013 Category: Pharmaceuticals Source Type: news

Correction
Nature 494, 7436 (2013). http://www.nature.com/doifinder/10.1038/494176f A table in the Outlook article 'Nanotechnology: Carrying drugs' (Nature491 (suppl. 7425), S58–S60; 201210.1038/491S58a) wrongly stated that Cerulean Pharma's drug CRLX101 is in phase I trials. In fact, it has been in phase II trials
Source: Nature - February 13, 2013 Category: Research Tags: Correction Source Type: research

Curtiss-Wright Declares Dividend of $0.09 Per Share for Common Stock
PARSIPPANY, N.J., Feb. 12, 2013 (GLOBE NEWSWIRE) -- Martin R. Benante, Chairman and CEO of Curtiss-Wright Corporation (NYSE:CW), announced that today the Board of Directors declared a dividend of nine cents ($0.09) per share on Curtiss-Wright Common Stock, payable April 11, 2013 to stockholders of record as of March 28, 2013.
Source: Medical News (via PRIMEZONE) - February 12, 2013 Category: Pharmaceuticals Source Type: news

RPX Announces Fourth Quarter and Fiscal Year 2012 Financial Results
SAN FRANCISCO, Feb. 12, 2013 (GLOBE NEWSWIRE) -- RPX Corporation (Nasdaq:RPXC), a leading provider of patent risk management solutions, today announced its financial results for the fourth quarter and year ended December 31, 2012.
Source: Medical News (via PRIMEZONE) - February 12, 2013 Category: Pharmaceuticals Source Type: news

RPX Names Goldman Sachs Banker Chief Financial Officer
SAN FRANCISCO, Feb. 12, 2013 (GLOBE NEWSWIRE) -- RPX Corporation (Nasdaq:RPXC), a leading provider of patent risk management solutions, today announced the selection of Ned Segal as Chief Financial Officer, effective no later than June 1, 2013. Mr. Segal joins RPX after almost 17 years with Goldman Sachs & Co., most recently as a Managing Director, Head of Global Software Investment Banking and COO of Technology Banking. Adam Spiegel, RPX's current CFO, is leaving the company to seek a new opportunity with an earlier stage company. RPX is working to ensure a seamless transition.
Source: Medical News (via PRIMEZONE) - February 12, 2013 Category: Pharmaceuticals Source Type: news

Trius Announces Publication of Tedizolid ESTABLISH 1 Trial in JAMA
SAN DIEGO, Feb. 12, 2013 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused on the discovery and development of innovative antibiotics for serious infections, announced today that the results from ESTABLISH 1, a Phase 3 study of tedizolid phosphate (TR-701) versus linezolid (Zyvox®) completed in 2011, have been published in
Source: Medical News (via PRIMEZONE) - February 12, 2013 Category: Pharmaceuticals Source Type: news

Lexington Realty Trust Announces Financings
NEW YORK, Feb. 12, 2013 (GLOBE NEWSWIRE) -- Lexington Realty Trust ("Lexington") (NYSE:LXP), a real estate investment trust (REIT) focused on single-tenant real estate investments, announced that it refinanced its existing secured credit facility with a senior unsecured credit facility, consisting of a revolving loan of up to $300.0 million and a term loan of up to $250.0 million. In addition, Lexington announced a $40.0 million mortgage financing secured by its property in Lenexa, Kansas and a $15.3 mortgage financing of a property in Palm Beach Gardens, Florida owned by a joint venture.
Source: Medical News (via PRIMEZONE) - February 12, 2013 Category: Pharmaceuticals Source Type: news

AB Klaipėdos nafta information
Referring to the decision of the Board of the Bank of Lithuania from 12 February 2013, to restrict the operation of Ūkio bankas, AB, please be informed that this will have no effect to the performance results or cash flow of the state-owned company Klaipėdos Nafta, AB.
Source: Medical News (via PRIMEZONE) - February 12, 2013 Category: Pharmaceuticals Source Type: news

National Research Corporation Announces Fourth Quarter and Year-End 2012 Results
LINCOLN, Neb., Feb. 12, 2013 (GLOBE NEWSWIRE) -- National Research Corporation (Nasdaq:NRCI) today announced results for the fourth quarter and year-end 2012.
Source: Medical News (via PRIMEZONE) - February 12, 2013 Category: Pharmaceuticals Source Type: news